ArticleVeterinary research communications2025
Detection and genomic characterization of foot and mouth disease virus SAT2 XIV topotype using amplicon-based nanopore sequencing.
Article in Veterinary research communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Current status and prospects of nanopore sequencing technology in the detection of pathogenic microorganisms.Frontiers in microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Foot and mouth disease (FMD) is a highly contagious vesicular viral disease that infects cloven-hoofed animals. This disease is caused by Foot-and-mouth disease virus (FMDV) which is composed of seven serotypes (O, A, C, Asia-1, SAT1, SAT2, and SAT3), each of which lacks cross immune protection among serotypes which complicates vaccination strategies. For that, sequencing of viral protein 1 (VP1) is crucial to identify circulating serotypes in a country. Jordan is endemic for FMD, with primarily O and A serotypes circulating according to previous data. However, the epidemiological status of FMD requires updates in Jordan. In this study, out of 200 samples collected during a recent outbreak in Al-Dhlail, Jordan in early 2023, forty-nine were positive by quantitative polymerase chain reaction (qPCR). Fourteen of these positive samples were selected for PCR amplification of the viral protein 1 (VP1) gene, which were then sequenced using nanopore technology. Phylogenetic analysis highlighted the presence of SAT2 XIV topotype, with eleven samples successfully sequenced using this approach. In addition to that, Sanger sequencing validated a N137S SNP in the VP1 protein that initially identified by our approach. This study provides additional data that can be used and incorporated into the national and global efforts against this disease with new means of diagnostics methods.
Indexed as
Identifiers
40106021What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.